Stock Analiz

National Health Investors Inc. (NHI) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

National Health Investors’s revenue went from $248M in fiscal 2016 to $376M in fiscal 2025, growth of about 4.7% a year.

Net income in fiscal 2025 was $142M, a net margin of 37.9%; the best year in this period was 2020 with $185M.

Over the twelve months to September 30, 2026, revenue was $456M and net income $697M.

Free cash flow was -$57M in fiscal 2025 and positive in 8 of the 10 years shown.

The diluted share count rose 20% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $248M162017: $279M172018: $295M182019: $318M192020: $333M202021: $299M212022: $278M222023: $320M232024: $335M242025: $376M25$376M
Net income
2016: $152M162017: $159M172018: $154M182019: $160M192020: $185M202021: $112M212022: $66M222023: $136M232024: $138M242025: $142M25$142M
Free cash flow
2016: -$218M162017: $22M172018: $60M182019: $4M192020: $115M202021: $161M212022: $174M222023: $135M232024: $50M242025: -$57M25-$57M
EPS (diluted)
2016: $3.87162017: $3.87172018: $3.67182019: $3.67192020: $4.14202021: $2.44212022: $1.48222023: $3.13232024: $3.13242025: $3.0225$3.02

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$456M$376M$335M$320M$278M$299M$333M$318M$295M$279M$248M
Gross profit———————————
Operating income———————————
Net income$697M$142M$138M$136M$66M$112M$185M$160M$154M$159M$152M
EPS (diluted)$14.24$3.02$3.13$3.13$1.48$2.44$4.14$3.67$3.67$3.87$3.87
R&D———————————
Revenue growth—+12.1%+4.8%+15.0%−6.9%−10.2%+4.6%+8.0%+5.7%+12.2%+8.5%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$234M$237M$208M$184M$185M$211M$232M$241M$208M$198M$177M
Capital spending—-$294M-$158M-$50M-$11M-$50M-$117M-$237M-$148M-$176M-$395M
Free cash flow$234M-$57M$50M$135M$174M$161M$115M$4M$60M$22M-$218M
Dividends paid$178M$170M$157M$156M$162M$183M$195M$180M$165M$153M$138M
Buybacks——$0$0$152M$0$0————
Stock-based pay$7M$6M$4M$5M$9M$8M$3M$4M$2M$3M$2M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$20M$24M$22M$19M$37M$43M$5M$5M$3M$5M
Debt—$1.2B$1.1B$1.1B$1.1B$1.2B$1.5B$1.4B$1.3B$1.1B$1.1B
Equity—$1.5B$1.4B$1.3B$1.3B$1.5B$1.5B$1.5B$1.4B$1.3B$1.2B
Total assets—$2.8B$2.6B$2.5B$2.5B$2.8B$3.1B$3.0B$2.8B$2.5B$2.4B
Shares (diluted)49M47M44M43M45M46M45M44M42M41M39M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin———————————
Operating margin———————————
Net margin153.0%37.9%41.2%42.4%23.9%37.4%55.6%50.4%52.4%57.2%61.0%
FCF margin51.4%-15.3%14.9%42.2%62.7%53.7%34.7%1.2%20.4%8.0%-87.8%
ROIC———————————
ROE—9.3%10.1%10.8%5.2%7.4%12.2%10.7%11.1%12.0%12.5%

Frequently asked questions

What is National Health Investors’s annual revenue?

$376M in fiscal 2025 and $456M over the twelve months to September 30, 2026.

How much profit does National Health Investors make?

Net income was $142M in fiscal 2025 (net margin 37.9%).

Is National Health Investors’s revenue growing?

Yes: revenue rose 12.1% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.